EXEL INDUSTRIES SA-A SHS (EXE.PA) Fundamental Analysis & Valuation

EPA:EXE • FR0004527638

Current stock price

32.3 EUR
-0.1 (-0.31%)
Last:

This EXE.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. EXE.PA Profitability Analysis

1.1 Basic Checks

  • In the past year EXE was profitable.
  • EXE had a positive operating cash flow in the past year.
  • Each year in the past 5 years EXE has been profitable.
  • EXE had a positive operating cash flow in 4 of the past 5 years.
EXE.PA Yearly Net Income VS EBIT VS OCF VS FCFEXE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M

1.2 Ratios

  • EXE has a Return On Assets (1.93%) which is in line with its industry peers.
  • EXE has a Return On Equity of 3.49%. This is in the lower half of the industry: EXE underperforms 61.11% of its industry peers.
  • EXE has a Return On Invested Capital (4.79%) which is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for EXE is in line with the industry average of 8.73%.
Industry RankSector Rank
ROA 1.93%
ROE 3.49%
ROIC 4.79%
ROA(3y)3.41%
ROA(5y)3.8%
ROE(3y)6.6%
ROE(5y)7.55%
ROIC(3y)6.85%
ROIC(5y)6.77%
EXE.PA Yearly ROA, ROE, ROICEXE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10

1.3 Margins

  • The Profit Margin of EXE (1.65%) is worse than 64.81% of its industry peers.
  • EXE's Profit Margin has declined in the last couple of years.
  • With a Operating Margin value of 3.80%, EXE is not doing good in the industry: 65.74% of the companies in the same industry are doing better.
  • EXE's Operating Margin has declined in the last couple of years.
  • The Gross Margin of EXE (48.37%) is better than 64.81% of its industry peers.
  • In the last couple of years the Gross Margin of EXE has grown nicely.
Industry RankSector Rank
OM 3.8%
PM (TTM) 1.65%
GM 48.37%
OM growth 3Y-0.11%
OM growth 5Y-4.11%
PM growth 3Y-17.34%
PM growth 5YN/A
GM growth 3Y1.85%
GM growth 5Y7.45%
EXE.PA Yearly Profit, Operating, Gross MarginsEXE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. EXE.PA Health Analysis

2.1 Basic Checks

  • EXE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • EXE has about the same amout of shares outstanding than it did 1 year ago.
  • EXE has about the same amout of shares outstanding than it did 5 years ago.
  • The debt/assets ratio for EXE has been reduced compared to a year ago.
EXE.PA Yearly Shares OutstandingEXE.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M
EXE.PA Yearly Total Debt VS Total AssetsEXE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • EXE has an Altman-Z score of 2.77. This is not the best score and indicates that EXE is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a decent Altman-Z score value of 2.77, EXE is doing good in the industry, outperforming 60.19% of the companies in the same industry.
  • EXE has a debt to FCF ratio of 3.06. This is a good value and a sign of high solvency as EXE would need 3.06 years to pay back of all of its debts.
  • The Debt to FCF ratio of EXE (3.06) is better than 66.67% of its industry peers.
  • EXE has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
  • EXE has a better Debt to Equity ratio (0.13) than 77.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 3.06
Altman-Z 2.77
ROIC/WACC0.71
WACC6.74%
EXE.PA Yearly LT Debt VS Equity VS FCFEXE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 1.84 indicates that EXE should not have too much problems paying its short term obligations.
  • The Current ratio of EXE (1.84) is better than 66.67% of its industry peers.
  • A Quick Ratio of 0.87 indicates that EXE may have some problems paying its short term obligations.
  • EXE has a worse Quick ratio (0.87) than 61.11% of its industry peers.
Industry RankSector Rank
Current Ratio 1.84
Quick Ratio 0.87
EXE.PA Yearly Current Assets VS Current LiabilitesEXE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. EXE.PA Growth Analysis

3.1 Past

  • The earnings per share for EXE have decreased strongly by -47.83% in the last year.
  • The earnings per share for EXE have been decreasing by -17.02% on average. This is quite bad
  • Looking at the last year, EXE shows a very negative growth in Revenue. The Revenue has decreased by -10.58% in the last year.
  • EXE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.44% yearly.
EPS 1Y (TTM)-47.83%
EPS 3Y-17.02%
EPS 5YN/A
EPS Q2Q%-38.37%
Revenue 1Y (TTM)-10.58%
Revenue growth 3Y0.2%
Revenue growth 5Y5.44%
Sales Q2Q%-11.03%

3.2 Future

  • Based on estimates for the next years, EXE will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.94% on average per year.
  • Based on estimates for the next years, EXE will show a decrease in Revenue. The Revenue will decrease by -2.59% on average per year.
EPS Next Y21.41%
EPS Next 2Y18.29%
EPS Next 3Y18.94%
EPS Next 5YN/A
Revenue Next Year-2.27%
Revenue Next 2Y0.61%
Revenue Next 3Y-2.59%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
EXE.PA Yearly Revenue VS EstimatesEXE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
EXE.PA Yearly EPS VS EstimatesEXE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

8

4. EXE.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 13.46 indicates a correct valuation of EXE.
  • EXE's Price/Earnings ratio is rather cheap when compared to the industry. EXE is cheaper than 81.48% of the companies in the same industry.
  • EXE is valuated cheaply when we compare the Price/Earnings ratio to 27.18, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 9.53 indicates a reasonable valuation of EXE.
  • EXE's Price/Forward Earnings ratio is rather cheap when compared to the industry. EXE is cheaper than 91.67% of the companies in the same industry.
  • EXE is valuated cheaply when we compare the Price/Forward Earnings ratio to 37.96, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.46
Fwd PE 9.53
EXE.PA Price Earnings VS Forward Price EarningsEXE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EXE indicates a rather cheap valuation: EXE is cheaper than 85.19% of the companies listed in the same industry.
  • 90.74% of the companies in the same industry are more expensive than EXE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 4.78
EV/EBITDA 4.67
EXE.PA Per share dataEXE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • EXE's earnings are expected to grow with 18.94% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.63
PEG (5Y)N/A
EPS Next 2Y18.29%
EPS Next 3Y18.94%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. EXE.PA Dividend Analysis

5.1 Amount

  • EXE has a Yearly Dividend Yield of 1.85%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 1.58, EXE pays a bit more dividend than its industry peers.
  • EXE's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.85%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
EXE.PA Yearly Dividends per shareEXE.PA Yearly Dividends per shareYearly Dividends per share 2019 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • EXE pays out 48.10% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP48.1%
EPS Next 2Y18.29%
EPS Next 3Y18.94%
EXE.PA Yearly Income VS Free CF VS DividendEXE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M -60M
EXE.PA Dividend Payout.EXE.PA Dividend Payout, showing the Payout Ratio.EXE.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

EXE.PA Fundamentals: All Metrics, Ratios and Statistics

EXEL INDUSTRIES SA-A SHS

EPA:EXE (4/13/2026, 7:00:00 PM)

32.3

-0.1 (-0.31%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)01-28
Earnings (Next)05-22
Inst Owners6.79%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap219.32M
Revenue(TTM)983.01M
Net Income(TTM)16.24M
Analysts48.89
Price Target38.76 (20%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.85%
Yearly Dividend1.15
Dividend Growth(5Y)N/A
DP48.1%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-4.2%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.05%
EPS NY rev (3m)-3.59%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.66%
Revenue NY rev (3m)-4.5%
Valuation
Industry RankSector Rank
PE 13.46
Fwd PE 9.53
P/S 0.22
P/FCF 4.78
P/OCF 3.1
P/B 0.47
P/tB 0.58
EV/EBITDA 4.67
EPS(TTM)2.4
EY7.43%
EPS(NY)3.39
Fwd EY10.49%
FCF(TTM)6.76
FCFY20.94%
OCF(TTM)10.43
OCFY32.28%
SpS144.77
BVpS68.62
TBVpS55.83
PEG (NY)0.63
PEG (5Y)N/A
Graham Number60.87
Profitability
Industry RankSector Rank
ROA 1.93%
ROE 3.49%
ROCE 6.65%
ROIC 4.79%
ROICexc 5.17%
ROICexgc 6.21%
OM 3.8%
PM (TTM) 1.65%
GM 48.37%
FCFM 4.67%
ROA(3y)3.41%
ROA(5y)3.8%
ROE(3y)6.6%
ROE(5y)7.55%
ROIC(3y)6.85%
ROIC(5y)6.77%
ROICexc(3y)7.59%
ROICexc(5y)7.7%
ROICexgc(3y)9.29%
ROICexgc(5y)9.68%
ROCE(3y)9.53%
ROCE(5y)9.41%
ROICexgc growth 3Y-4.12%
ROICexgc growth 5Y-5.56%
ROICexc growth 3Y-2.57%
ROICexc growth 5Y-3.96%
OM growth 3Y-0.11%
OM growth 5Y-4.11%
PM growth 3Y-17.34%
PM growth 5YN/A
GM growth 3Y1.85%
GM growth 5Y7.45%
F-Score7
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 3.06
Debt/EBITDA 0.92
Cap/Depr 79.73%
Cap/Sales 2.53%
Interest Coverage 5.82
Cash Conversion 103.29%
Profit Quality 282.72%
Current Ratio 1.84
Quick Ratio 0.87
Altman-Z 2.77
F-Score7
WACC6.74%
ROIC/WACC0.71
Cap/Depr(3y)84.53%
Cap/Depr(5y)85.26%
Cap/Sales(3y)2.38%
Cap/Sales(5y)2.34%
Profit Quality(3y)163.79%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-47.83%
EPS 3Y-17.02%
EPS 5YN/A
EPS Q2Q%-38.37%
EPS Next Y21.41%
EPS Next 2Y18.29%
EPS Next 3Y18.94%
EPS Next 5YN/A
Revenue 1Y (TTM)-10.58%
Revenue growth 3Y0.2%
Revenue growth 5Y5.44%
Sales Q2Q%-11.03%
Revenue Next Year-2.27%
Revenue Next 2Y0.61%
Revenue Next 3Y-2.59%
Revenue Next 5YN/A
EBIT growth 1Y-33.86%
EBIT growth 3Y0.09%
EBIT growth 5Y1.1%
EBIT Next Year105.8%
EBIT Next 3Y31.99%
EBIT Next 5YN/A
FCF growth 1Y137.81%
FCF growth 3YN/A
FCF growth 5Y1.4%
OCF growth 1Y42.89%
OCF growth 3YN/A
OCF growth 5Y5.62%

EXEL INDUSTRIES SA-A SHS / EXE.PA Fundamental Analysis FAQ

What is the fundamental rating for EXE stock?

ChartMill assigns a fundamental rating of 4 / 10 to EXE.PA.


What is the valuation status for EXE stock?

ChartMill assigns a valuation rating of 8 / 10 to EXEL INDUSTRIES SA-A SHS (EXE.PA). This can be considered as Undervalued.


How profitable is EXEL INDUSTRIES SA-A SHS (EXE.PA) stock?

EXEL INDUSTRIES SA-A SHS (EXE.PA) has a profitability rating of 4 / 10.


What is the valuation of EXEL INDUSTRIES SA-A SHS based on its PE and PB ratios?

The Price/Earnings (PE) ratio for EXEL INDUSTRIES SA-A SHS (EXE.PA) is 13.46 and the Price/Book (PB) ratio is 0.47.


How financially healthy is EXEL INDUSTRIES SA-A SHS?

The financial health rating of EXEL INDUSTRIES SA-A SHS (EXE.PA) is 5 / 10.